Physician profile
Michael S Shuler
NPI 1497944565
$99,227.92
in general payments reported to CMS, 2019-2025
7 companies · $13K in 2025
The $13K reported for 2025 was more than what 94% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $10K · 2021: $15K · 2022: $4,381 · 2023: $7,327 · 2024: $8,498 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $28K · Food and Beverage: $55.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $28,342.32 |
| Food and Beverage | $55.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $96,088.29 | 2019-2025 | Linvatec Burs and Blades, Trueshot |
| Microaire Surgical Instruments LLC | $2,400.00 | 2019 | |
| Axogen | $502.60 | 2019 | |
| Depuy Synthes Sales INC. | $151.65 | 2020-2023 | Na |
| Medline Industries LP | $37.18 | 2024-2025 | Medline Industries, INC. |
| Stryker Corporation | $25.52 | 2021 | |
| Horizon Therapeutics Plc | $22.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shuler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.